Reduced lymphocyte subpopulations in patients with advanced or disseminated melanoma
- 31 May 1993
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 28 (5) , 738-744
- https://doi.org/10.1016/0190-9622(93)70103-z
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignanciesThe Lancet, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- UVA sunbeds: tanning, photoprotection, acute adverse effects and immunological changesBritish Journal of Dermatology, 1989
- Diurnal variation of lymphocyte subsets identified by monoclonal antibodies.BMJ, 1983
- Senescence of the Immune SystemMedical Clinics of North America, 1983
- Reversible Alterations in Immunoregulatory T Cells in SmokingChest, 1982
- Low natural-killer-cell activity in familial melanoma patients and their relativesBritish Journal of Cancer, 1979
- Relationship between T and B lymphocyte values and prognosis in malignant melanomaBritish Journal of Dermatology, 1978
- Distribution of Latex-Ingesting Cells, T Cells, and BCells in the Peripheral Blood of Patients With Malignant Melanoma23JNCI Journal of the National Cancer Institute, 1975
- Thymus-Derived Rosette-Forming Cells in Various Human Disease States: Cancer, Lymphoma, Bacterial and Viral Infections, and Other DiseasesJournal of Clinical Investigation, 1973